MPC
60
8
TGNA
56
3
KEY
70
3
ORLY
60
6
DFS
67
5
ECL
59
-3
SO
59
-3
SRE
38
-4
XOM
62
3
CME
42
5
DOV
69
6
SPG
48
-2
VNO
50
3
AMGN
55
-12
TXN
40
-2
STI
24
-2
EQR
45
-3
LMT
59
2
UPS
45
5
RIG
60
14
MPC
60
8
TGNA
56
3
KEY
70
3
ORLY
60
6
DFS
67
5
ECL
59
-3
SO
59
-3
SRE
38
-4
XOM
62
3
CME
42
5
DOV
69
6
SPG
48
-2
VNO
50
3
AMGN
55
-12
TXN
40
-2
STI
24
-2
EQR
45
-3
LMT
59
2
UPS
45
5
RIG
60
14
Financhill
Back

Cogent Biosciences 10K Form

Buy
59

COGT
Cogent Biosciences

Last Price:
9.52
Seasonality Move:
-9.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10 10Q COGT/Cogent Biosciences Quarterly
2020-05-11 10Q COGT/Cogent Biosciences Quarterly
2020-03-13 10K COGT/Cogent Biosciences Annual
2019-11-12 10Q COGT/Cogent Biosciences Quarterly
2019-08-09 10Q COGT/Cogent Biosciences Quarterly
2019-05-10 10Q COGT/Cogent Biosciences Quarterly

Receive COGT News And Ratings

See the #1 stock for the next 7 days that we like better than COGT

COGT Financial Statistics

Sales & Book Value

Annual Sales: $7.87M
Cash Flow: $-52.6M
Price / Cash Flow: 0
Annual Sales: $2.09
Price / Book: 5.04

Profitability

EPS (TTM): -2.48000
Net Income (TTM): $-212.17M
Gross Margin: $72.86M
Return on Equity: 0%
Return on Assets: 0%

Cogent Biosciences Earnings Forecast

Key Cogent Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for COGT is 871.53%.
  • The Selling, General & Administrative Expenses for COGT have been equal to 221.34% of Gross Profit Margin.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Cogent Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: COGT
CUSIP: 19240Q
Website: cogentbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

COGT Technical Analysis vs Fundamental Analysis

Buy
59
Cogent Biosciences (COGT) is a Buy

Is Cogent Biosciences a Buy or a Sell?